NaSH pretreatment decreased myocardial infarction size, maintained left ventricular function, suppressed apoptosis, and lowered levels of ER/SR stress protein markers Glucose-Regulated Protein 78 (GRP78), CCAAT/enhancer-binding protein homologous protein (CHOP), and ATF6. Here, DDIT3 is linked to myocardial infarction.